Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Ferrara

Showing results (41-50 of 143) with videos related to

Pageof 15
Sort By:
Mikrochimica Acta|September 7, 2024
Wearable electrochemical device based on butterfly-like paper-based microfluidics for pH and Na<sup>+</sup> monitoring in sweatLuca Fiore, Vincenzo Mazzaracchio, Arianna Antinucci, et al.
Expert Review of Anticancer Therapy|December 21, 2017
The development of PARP as a successful target for cancer therapyRoberto Ferrara, Francesca Simionato, Chiara Ciccarese, et al.
Children (Basel, Switzerland)|May 28, 2022
Unexpected Huge Prevalence of Intracardiac Extension of Wilms Tumor-A Single Center Experience from a Ugandan HospitalMassimo Mapelli, Paola Zagni, Roberto Ferrara, et al.
Diagnostics (Basel, Switzerland)|May 27, 2023
Effects of SARS-CoV-2 on Pulmonary Function and Muscle Strength Testing in Military Subjects According to the Period of Infection: Cross-Sectional StudyJosuel Ora, Paola Rogliani, Federica Ferron, et al.
The Oncologist|October 7, 2025
Health-related quality of life assessment in trials testing tyrosine kinase inhibitors or immune checkpoints inhibitors in early-stage NSCLCFabio Salomone, Giorgia Novero, Oriana Ciani, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 11, 2014
Immune checkpoint inhibitors for non-small-cell lung cancer: does that represent a 'new frontier'?Sara Pilotto, Stefania Kinspergher, Umberto Peretti, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|October 6, 2022
RET rearrangements in non-small cell lung cancer: Evolving treatment landscape and future challengesAlberto Servetto, Daniela Esposito, Roberto Ferrara, et al.
Journal of Thoracic Disease|June 29, 2018
Do immune checkpoint inhibitors need new studies methodology?Roberto Ferrara, Sara Pilotto, Mario Caccese, et al.
Journal of Functional Morphology and Kinesiology|June 26, 2024
Upper-Limb Muscle Fatigability in Para-Athletes Quantified as the Rate of Force Development in Rapid Contractions of Submaximal AmplitudeGennaro Boccia, Paolo Riccardo Brustio, Luca Beratto, et al.
Clinical Endocrinology|February 21, 2006
First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trialAnnamaria Colao, Rosario Pivonello, Francesca Rosato, et al.
Pageof 15

Showing results (41-50 of 143) with videos related to

Sort By:
Pageof 15
Mikrochimica Acta|September 7, 2024
Wearable electrochemical device based on butterfly-like paper-based microfluidics for pH and Na<sup>+</sup> monitoring in sweatLuca Fiore, Vincenzo Mazzaracchio, Arianna Antinucci, et al.
Expert Review of Anticancer Therapy|December 21, 2017
The development of PARP as a successful target for cancer therapyRoberto Ferrara, Francesca Simionato, Chiara Ciccarese, et al.
Children (Basel, Switzerland)|May 28, 2022
Unexpected Huge Prevalence of Intracardiac Extension of Wilms Tumor-A Single Center Experience from a Ugandan HospitalMassimo Mapelli, Paola Zagni, Roberto Ferrara, et al.
Diagnostics (Basel, Switzerland)|May 27, 2023
Effects of SARS-CoV-2 on Pulmonary Function and Muscle Strength Testing in Military Subjects According to the Period of Infection: Cross-Sectional StudyJosuel Ora, Paola Rogliani, Federica Ferron, et al.
The Oncologist|October 7, 2025
Health-related quality of life assessment in trials testing tyrosine kinase inhibitors or immune checkpoints inhibitors in early-stage NSCLCFabio Salomone, Giorgia Novero, Oriana Ciani, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 11, 2014
Immune checkpoint inhibitors for non-small-cell lung cancer: does that represent a 'new frontier'?Sara Pilotto, Stefania Kinspergher, Umberto Peretti, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|October 6, 2022
RET rearrangements in non-small cell lung cancer: Evolving treatment landscape and future challengesAlberto Servetto, Daniela Esposito, Roberto Ferrara, et al.
Journal of Thoracic Disease|June 29, 2018
Do immune checkpoint inhibitors need new studies methodology?Roberto Ferrara, Sara Pilotto, Mario Caccese, et al.
Journal of Functional Morphology and Kinesiology|June 26, 2024
Upper-Limb Muscle Fatigability in Para-Athletes Quantified as the Rate of Force Development in Rapid Contractions of Submaximal AmplitudeGennaro Boccia, Paolo Riccardo Brustio, Luca Beratto, et al.
Clinical Endocrinology|February 21, 2006
First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trialAnnamaria Colao, Rosario Pivonello, Francesca Rosato, et al.
Pageof 15